Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    cholangiocarcinoma AND cca | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Nab-Paclitaxel and Gemcitabine
2 Unknown  Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Conditions: Hilar Cholangiocarcinoma;   Primary Sclerosing Cholangitis
Interventions: Procedure: Liver transplantation;   Radiation: 45 Gy external radiations;   Radiation: Endoluminal bile duct Brachytherapy;   Drug: Capecitabine;   Procedure: Pre liver transplantation laparoscopic hand assisted staging
3 Unknown  Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Condition: Advanced Intrahepatic Cholangiocarcinoma
Intervention: Drug: Calcitriol
4 Not yet recruiting Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Interventions: Procedure: bilateral metal stent insertion;   Procedure: unilateral metal stent insertion
5 Recruiting A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Condition: Cholangiocarcinoma
Interventions: Drug: Amphinex and Gemcitabine;   Drug: Gemcitabine and Cisplatin
6 Recruiting RFA RCT for Pancreatic or Bile Duct Cancer
Conditions: Unresectable Pancreatic Cancer;   Cholangiocarcinoma Non-resectable
Interventions: Procedure: Radiofrequency Ablation using EndoHPB Probe;   Procedure: Stenting only
7 Recruiting The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells
Condition: Cholangiocarcinoma
Intervention: Drug: cytokine induced killer cells

Indicates status has not been verified in more than two years